With advances in systemic therapies that do not cross the blood-brain barrier, the burden of intracranial metastatic disease (IMD) as a complication of cancer is expected to increase. In this Research Topic, we propose to review the basic biology of IMD and the implications of this biology on management of ...
With advances in systemic therapies that do not cross the blood-brain barrier, the burden of intracranial metastatic disease (IMD) as a complication of cancer is expected to increase. In this Research Topic, we propose to review the basic biology of IMD and the implications of this biology on management of brain metastasis. Topics will include discussion of chemotherapy, targeted therapy, immunotherapy, radiation therapy and surgery. Current standards of care and future goals will be articulated.
Keywords:
Brain metastasis, intracranial metastatic disease, surgery, radiation, chemotherapy
Important Note:
All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.